After finishing undergraduate studies at the University of California, Davis, in 1971, Randi Hagerman received her medical doctorate from Stanford Medical School and went on to specialize in pediatrics and neuroscience. She now does clinical work as a developmental behavioral pediatrician and is a leading researcher of fragile X syndrome, a condition where genetic mutations on the X chromosome result in varying levels of intellectual disability. Hagerman is a distinguished professor of pediatrics and the medical director of the MIND Institute at the University of California, Davis. She is currently running screening studies for fragile X syndrome in Mexico, the Philippines, and Colombia. Hagerman and her colleagues have also been involved in training programs for doctors and health-care professionals on neurodevelopmental disorders. In this issue of The Scientist, Hagerman writes about our current understanding of fragile X syndrome and the experimental treatments going through clinical trials.
Scientist and science communicator ...
